F
$ Value
$1.9M
Shares
8,037
Price
$232
Filed
Mar 3
Insider
Name
Thakkar Roopal
Title
EVP, R&D and CSO
CIK
0002004979
Roles
Officer
Transaction Details
Transaction Date
2026-02-27
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
52,376
Footnotes
Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature. This was inadvertently omitted from the Form 3 filed on December 22, 2023.
Filing Info
Thakkar Roopal's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | ABBV | F | $1.9M |
| 2026-02-18 | ABBV | A | $0 |
| 2026-02-18 | ABBV | A | $0 |
| 2026-02-18 | ABBV | A | $0 |
| 2026-02-18 | ABBV | A | $0 |
| 2026-02-18 | ABBV | A | $0 |
Other Insiders at ABBV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RAPP EDWARD J | — | — | 2026-03-31 |
| Alpern Robert J | — | — | 2026-03-31 |
|
SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER
|
— | — | 2026-02-27 |
|
Michael Robert A.
CHAIRMAN OF THE BOARD AND CEO
|
— | — | 2026-02-27 |
|
Michael Robert A.
CHIEF EXECUTIVE OFFICER
|
— | — | 2026-02-18 |
|
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
|
— | — | 2026-02-27 |
|
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
|
— | — | 2026-02-27 |
|
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
|
— | — | 2026-02-27 |
|
Siatis Perry C
EVP, GC AND SECRETARY
|
— | $9.5M | 2026-03-02 |
| Quaggin Susan E | — | — | 2026-03-31 |
|
Thakkar Roopal
EVP, R&D and CSO
|
— | — | 2026-02-18 |
|
Purdue David Ryan
SVP, Controller
|
— | $1.2M | 2026-03-04 |
|
Crum Demetris D
EVP, CHIEF HR OFFICER
|
— | — | 2026-02-27 |